Feature Channels:

Drug Resistance

Add to Favorites Subscribe Share
Newswise: Taking One for the Team: How Bacteria Self-Destruct to Fight Viral Infections
  • Embargo expired:
    10-Jan-2020 11:00 AM EST

Taking One for the Team: How Bacteria Self-Destruct to Fight Viral Infections

University of California San Diego Health

UC San Diego School of Medicine researchers have discovered how a new immune system works to protect bacteria from phages, viruses that infect bacteria — new information that could be leveraged to improve treatment of multidrug-resistant bacterial infections by refining phage therapy.

Channels: Drug Resistance, Immunology, Infectious Diseases, Pharmaceuticals, National Institutes of Health (NIH), All Journal News,

Released:
8-Jan-2020 4:05 PM EST

Why It Matters: Prescription for Disaster

Council on Foreign Relations (CFR)

Bacteria are becoming increasingly resistant to antibiotics. A major cause is their overuse in both humans and animals. At the same time, a lack of financial incentives is setting back efforts to discover new classes of antibiotics. The problem is both global and local, and without new initiatives, many common medical conditions could become deadly once again.

Channels: All Journal News, Drug Resistance, Healthcare, Infectious Diseases, Pharmaceuticals, Government/Law, U.S. Foreign Relations, Staff Picks,

Released:
31-Dec-2019 10:15 AM EST
Research Results

Law and Public Policy

Closing of Second Antibiotic Company Highlights Urgent Need for Investment in Infection Fighting Drugs

Infectious Diseases Society of America (IDSA)

Earlier today, a release was issued stating that antibiotic maker Melinta is closing. This information was incorrect. Melinta has filed for Chapter 11 bankruptcy but intends to remain open and is in the process of restructuring. The bankruptcy filing announced today by antibiotic maker Melinta once again highlights the daunting challenges facing research and development of new infection-fighting drugs.

Channels: Business Ethics, Drug Resistance, Pharmaceuticals, Public Health, Infectious Diseases,

Released:
30-Dec-2019 4:00 AM EST
Feature Tip Sheet
HMH-Logo.jpg

Hackensack Meridian Southern Region Hospitals Receive N.J. Antimicrobial Stewardship Program Awards

Hackensack Meridian Health

The Antimicrobial Stewardship Programs at Hackensack Meridian Health southern region hospitals were recognized by the New Jersey Department of Health for their dedication to antimicrobial stewardship at the New Jersey Antimicrobial Stewardship Collaborative Annual Conference Thursday, December 5.

Channels: Drug Resistance, Healthcare, In the Workplace, Infectious Diseases, Patient Safety, Public Health,

Released:
20-Dec-2019 12:45 PM EST
Feature
Newswise: New Therapeutic Strategy for Chemotherapy Resistance in Ovarian Cancer

New Therapeutic Strategy for Chemotherapy Resistance in Ovarian Cancer

Wistar Institute

A Wistar study demonstrated that NAMPT, an enzyme critical for NAD+ biosynthesis, mediates selection of stem-like chemoresistant cells following cisplatin treatment.

Channels: All Journal News, Cancer, Drug Resistance, OBGYN, Pharmaceuticals, Women's Health,

Released:
19-Dec-2019 10:40 AM EST
Announcement
Newswise: New CRISPR-based System Targets Amplified Antibiotic-resistant Genes
  • Embargo expired:
    16-Dec-2019 5:00 AM EST

New CRISPR-based System Targets Amplified Antibiotic-resistant Genes

University of California San Diego

Researchers have developed a new CRISPR-based gene-drive system that more efficiently inactivates a gene rendering bacteria antibiotic-resistant. The new system leverages technology developed by UC San Diego biologists in insects and mammals that biases genetic inheritance of preferred traits called “active genetics.”

Channels: All Journal News, Drug Resistance, Genetics, Nature (journal),

Released:
12-Dec-2019 6:05 PM EST
Research Results
JHSPH-new-logo.jpg

Survey: Majority of Voters Surveyed Support Greater Oversight of Industrial Animal Farms

Johns Hopkins Bloomberg School of Public Health

A new survey released by the Johns Hopkins Center for a Livable Future finds that the majority of registered voters support greater oversight of industrial animal farms. The Center for a Livable Future is based at the Johns Hopkins Bloomberg School of Public Health.

Channels: All Journal News, Drug Resistance, Food and Water Safety, Food Science, Pollution, Public Health,

Released:
10-Dec-2019 11:30 AM EST
Research Results
Newswise: Researchers identify ‘Achilles’ heel’ of drug-resistant superbug

Researchers identify ‘Achilles’ heel’ of drug-resistant superbug

University of Texas Health Science Center at Houston

Researchers at The University of Texas Health Science Center at Houston (UTHealth) have identified a protein that allows vancomycin-resistant enterococci to defy antibiotic treatment and immune system attacks. Their discovery opens the door for future treatment options in the fight against antibiotic resistance.

Channels: All Journal News, Drug Resistance, Healthcare, Immunology, Infectious Diseases, Microbiome, Pharmaceuticals, Grant Funded News,

Released:
9-Dec-2019 3:15 PM EST
Research Results

Current treatment for fungal meningitis is fueling drug resistance

University of Liverpool

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

Channels: AIDS and HIV, All Journal News, Immunology, Infectious Diseases, Public Health, Drug Resistance,

Released:
6-Dec-2019 3:05 PM EST
Research Results
Newswise: Calcium Signaling Identified as Exploitable Target in Addressing Drug Resistance to Non-Hodgkin Lymphoma Treatment

Calcium Signaling Identified as Exploitable Target in Addressing Drug Resistance to Non-Hodgkin Lymphoma Treatment

Rutgers Cancer Institute of New Jersey

Gene expression profiling and other analyses conducted by Rutgers Cancer Institute of New Jersey researchers and colleagues examining drug resistance to a common antibody therapy for non-Hodgkin lymphoma have identified calcium signaling as a novel and exploitable target in overcoming this treatment obstacle. Results are being presented at the American Society of Hematology Annual Meeting.

Channels: Medical Meetings, All Journal News, Cancer, Drug Resistance,

Released:
2-Dec-2019 2:35 PM EST
Research Results


5.08378